AIA
BVS icon

Affinity Investment Advisors’s Bioventus BVS Stock Holding History

Affinity Investment Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-56,570
Closed -$396K – 198
2022
Q3 		$396K Hold
56,570
– – 0.21% 155
2022
Q2 		$386K Sell
56,570
-1,880
-3% -$19.2K 0.19% 159
2022
Q1 		$824K Sell
58,450
-1,580
-3% -$21.1K 0.34% 107
2021
Q4 		$870K Buy
60,030
+1,460
+2% +$20.8K 0.35% 107
2021
Q3 		$829K Buy
58,570
+13,630
+30% +$210K 0.37% 101
2021
Q2 		$791K Buy
+44,940
New +$724K 0.36% 105

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Affinity Investment Advisors's BVS Position: Q4 2022 in Review

Affinity Investment Advisors sold out of Bioventus (BVS) in Q4 2022, closing a stake of 56,570 shares — an estimated $396K sold.

Affinity Investment Advisors first reported a position in BVS in Q2 2021 and held it in 6 quarters. The position peaked at $870K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Affinity Investment Advisors reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Affinity Investment Advisors sold 56,570 Bioventus shares in Q4 2022, an estimated $396K.
  • Affinity Investment Advisors first reported a position in Bioventus in Q2 2021 and held it in 6 quarters.
  • Affinity Investment Advisors's Bioventus position peaked at $870K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Affinity Investment Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.